Calpol and meningitis B vaccine Bexsero

Calpol and meningitis B vaccine Bexsero

C026/3255 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 60.1MB

Downloadable file size: 10.2MB

Price image Pricing

Please login to use the price calculator


Restrictions: Editorial use only Not to be shared on social media or embedded in a web page without permission.

Caption: Calpol and meningitis B vaccine Bexsero. Packet of Calpol (upper centre) and pre-filled syringes (lower left) of Bexsero. Calpol is a syrup formulation for children. It contains paracetamol, and is used to treat fever and pain associated with colds and flu. Bexsero is the meningococcal vaccine used against meningitis B, a disease caused by serogroup B of the Neisseria meningitidis bacterium. Meningitis is a potentially fatal inflammation of the brain membranes (meninges). This vaccine was developed by Novartis and approved for use in the European Union in January 2013. It was added to the UK childhood immunisation programme from 1 September 2015.

Release details: Model release not required. Property release not required.

Keywords: 2015, 21st century, analgesic, antipyretic, bacterial, bexsero, calpol, childhood, fever treatment, glaxosmithkline, group b, immunisation, immunization, infant, intramuscular, medical, medicine, meningitis b, meningococcal, neisseria meningitidis, no-one, nobody, novartis, packaging, packet, paediatric, paediatrics, pain relief, painkiller, paracetamol, pediatrics, pharmaceutical, pharmaceutics, pharmacological, pharmacology, pre-filled, rdna, serogroup b, still life, still-life, strawberry flavour, studio shot, sugar free, suspension, syringe, syringes, vaccine, white background

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.